| scholarly article | Q13442814 |
| P50 | author | Roger Chammas | Q85912809 |
| Anamaria Aranha Camargo | Q37616056 | ||
| P2093 | author name string | Fu-Tong Liu | |
| Suely Nonogaki | |||
| Emerson Soares Bernardes | |||
| Camila Maria Longo Machado | |||
| Fabrício Falconi Costa | |||
| Camila Morais Melo | |||
| Luciana Nogueira Sousa Andrade | |||
| Sofia Nascimento dos Santos | |||
| Verônica Rodrigues Teixeira | |||
| P2860 | cites work | Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes | Q24534395 |
| Galectin-3 regulates myofibroblast activation and hepatic fibrosis | Q24546358 | ||
| Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications | Q24561689 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer | Q28297827 | ||
| TGF-beta signaling in tumor suppression and cancer progression | Q29615427 | ||
| Transforming growth factor-beta (TGF beta) is chemotactic for human monocytes and induces their expression of angiogenic activity | Q69048985 | ||
| Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors | Q30885681 | ||
| VEGFR1 and VEGFR2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis | Q31121321 | ||
| Lack of galectin-3 disturbs mesenteric lymph node homeostasis and B cell niches in the course of Schistosoma mansoni infection. | Q33900663 | ||
| Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples | Q34014559 | ||
| Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response | Q34096563 | ||
| TGFβ signaling plays a critical role in promoting alternative macrophage activation | Q34306291 | ||
| Galectins as modulators of tumour progression | Q34381235 | ||
| Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma | Q34543033 | ||
| Melanocyte transformation associated with substrate adhesion impediment. | Q35052171 | ||
| Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells | Q35314084 | ||
| Galectin-3 induces endothelial cell morphogenesis and angiogenesis | Q35809815 | ||
| Targeted disruption of the galectin-3 gene results in attenuated peritoneal inflammatory responses. | Q35809897 | ||
| Expression of PAFR as part of a prosurvival response to chemotherapy: a novel target for combination therapy in melanoma. | Q35915423 | ||
| Epigenetic reprogramming as a key contributor to melanocyte malignant transformation. | Q35985447 | ||
| Role of galectin-3 in classical and alternative macrophage activation in the liver following acetaminophen intoxication | Q36456913 | ||
| Galectin-3 cleavage: a novel surrogate marker for matrix metalloproteinase activity in growing breast cancers. | Q36733651 | ||
| Macrophages and Tissue Injury: Agents of Defense or Destruction? | Q36896804 | ||
| Transforming growth factor-beta in cutaneous melanoma | Q37143532 | ||
| Evidence of heavy methylation in the galectin 3 promoter in early stages of prostate adenocarcinoma: development and validation of a methylated marker for early diagnosis of prostate cancer | Q37313689 | ||
| Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation | Q37594369 | ||
| Sp1 binding is inhibited by (m)Cp(m)CpG methylation. | Q38343513 | ||
| Galectin-3 accelerates M2 macrophage infiltration and angiogenesis in tumors | Q39180434 | ||
| Galectin-1 is silenced by promoter hypermethylation and its re-expression induces apoptosis in human colorectal cancer cells | Q39625206 | ||
| Regulation of alternative macrophage activation by galectin-3. | Q40016366 | ||
| Differential expression of galectins in normal, benign and malignant prostate epithelial cells: silencing of galectin-3 expression in prostate cancer by its promoter methylation | Q40137078 | ||
| Proteomic and SAGE profiling of murine melanoma progression indicates the reduction of proteins responsible for ROS degradation. | Q40326208 | ||
| Effects of DNA methylation on galectin-3 expression in pituitary tumors. | Q40453894 | ||
| Transient inflammatory response induced by apoptotic cells is an important mediator of melanoma cell engraftment and growth | Q40486064 | ||
| The role of the tumor microenvironment in regulating angiogenesis | Q42703796 | ||
| Shuttling of galectin-3 between the nucleus and cytoplasm. | Q42813718 | ||
| Galectin-3 contributes to neonatal hypoxic-ischemic brain injury | Q43201355 | ||
| Hypoxia-induced secretion of TGF-β1 in mesenchymal stem cell promotes breast cancer cell progression. | Q45947919 | ||
| DAMGO-induced expression of chemokines and chemokine receptors: the role of TGF-beta1. | Q46770172 | ||
| Association of galectin-3 expression with melanoma progression and prognosis. | Q54551094 | ||
| Inhibition of endothelial cell proliferation by type β-transforming growth factor: Interactions with acidic and basic fibroblast growth factors | Q56429120 | ||
| Galectin-3 Expression Is Associated with Tumor Progression and Pattern of Sun Exposure in Melanoma | Q57741332 | ||
| High yield electroblotting onto polyvinylidene difluoride membranes from polyacrylamide gels | Q68127118 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 201-214 | |
| P577 | publication date | 2014-01-12 | |
| P1433 | published in | Cancer Medicine | Q27724564 |
| P1476 | title | Galectin-3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGFβ1-induced macrophages | |
| P478 | volume | 3 |
| Q38246351 | A potential pathophysiological role for galectins and the renin-angiotensin system in preeclampsia |
| Q55119445 | Anti-CTLA-4 based therapy elicits humoral immunity to galectin-3 in patients with metastatic melanoma. |
| Q28075996 | Dysregulation of TGFβ1 Activity in Cancer and Its Influence on the Quality of Anti-Tumor Immunity |
| Q38225141 | Extracellular galectin-3 in tumor progression and metastasis. |
| Q26744513 | Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor Microenvironments |
| Q92713370 | Galectin-3 Regulates the Expression of Tumor Glycosaminoglycans and Increases the Metastatic Potential of Breast Cancer |
| Q41472543 | Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activation |
| Q90073141 | Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases |
| Q36326176 | Galectin-3 as a Potential Target to Prevent Cancer Metastasis. |
| Q27687444 | Galectin-3 in angiogenesis and metastasis. |
| Q35392528 | Galectin-3 up-regulation in hypoxic and nutrient deprived microenvironments promotes cell survival |
| Q38214808 | Galectins and neovascularization in central nervous system tumors |
| Q34414227 | Glycobiology of ocular angiogenesis |
| Q35906920 | Identification of polarized macrophage subsets in zebrafish |
| Q53743967 | Immune-Mediated and Hypoxia-Regulated Programs: Accomplices in Resistance to Anti-angiogenic Therapies. |
| Q41340042 | Promising landscape for regulating macrophage polarization: epigenetic viewpoint |
| Q26991865 | Regulatory role of glycans in the control of hypoxia-driven angiogenesis and sensitivity to anti-angiogenic treatment |
| Q36104317 | The deficiency of galectin-3 in stromal cells leads to enhanced tumor growth and bone marrow metastasis |
Search more.